TET2 c.2060C>T ;(p.A687V)

Variant ID: 4-106157159-C-T

NM_001127208.2(TET2):c.2060C>T;(p.A687V)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.

Nature Genetics
Kar, Siddhartha P SP; Quiros, Pedro M PM; Gu, Muxin M; Jiang, Tao T; Mitchell, Jonathan J; Langdon, Ryan R; Iyer, Vivek V; Barcena, Clea C; Vijayabaskar, M S MS; Fabre, Margarete A MA; Carter, Paul P; Petrovski, Slavé S; Burgess, Stephen S; Vassiliou, George S GS
Publication Date: 2022-08

Variant appearance in text: TET2: A687V
PubMed Link: 35835912
Variant Present in the following documents:
  • 41588_2022_1121_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.

Frontiers In Oncology
Han, Mei M; Jia, Lina L; Lv, Wencai W; Wang, Lihui L; Cui, Wei W
Publication Date: 2019

Variant appearance in text: TET2: A687V
PubMed Link: 30984620
Variant Present in the following documents:
  • Main text
  • fonc-09-00194.pdf
View BVdb publication page



Polycomb complexes in normal and malignant hematopoiesis.

The Journal Of Cell Biology
Di Carlo, Valerio V; Mocavini, Ivano I; Di Croce, Luciano L
Publication Date: 2019-01-07

Variant appearance in text: TET2: A687V
PubMed Link: 30341152
Variant Present in the following documents:
  • JCB_201808028_sm.pdf
View BVdb publication page



Polycomb Repressor Complex 2 in Genomic Instability and Cancer.

International Journal Of Molecular Sciences
Veneti, Zoe Z; Gkouskou, Kalliopi K KK; Eliopoulos, Aristides G AG
Publication Date: 2017-07-30

Variant appearance in text: TET2: A687V
PubMed Link: 28758948
Variant Present in the following documents:
  • ijms-18-01657.pdf
View BVdb publication page



Targeting EZH2 and PRC2 dependence as novel anticancer therapy.

Experimental Hematology
Xu, Bowen B; Konze, Kyle D KD; Jin, Jian J; Wang, Gang Greg GG
Publication Date: 2015-08

Variant appearance in text: TET2: A687V
PubMed Link: 26027790
Variant Present in the following documents:
  • Main text
View BVdb publication page



Chromatin signatures of cancer.

Genes & Development
Morgan, Marc A MA; Shilatifard, Ali A
Publication Date: 2015-02-01

Variant appearance in text: TET2: A687V
PubMed Link: 25644600
Variant Present in the following documents:
  • 238.pdf
View BVdb publication page



Regulation and Role of EZH2 in Cancer.

Cancer Research And Treatment
Yamaguchi, Hirohito H; Hung, Mien-Chie MC
Publication Date: 2014-07

Variant appearance in text: TET2: A687V
PubMed Link: 25038756
Variant Present in the following documents:
  • Main text
  • crt-46-3-209.pdf
View BVdb publication page



Driver mutations of cancer epigenomes.

Protein & Cell
Roy, David M DM; Walsh, Logan A LA; Chan, Timothy A TA
Publication Date: 2014-04

Variant appearance in text: TET2: A687V
PubMed Link: 24622842
Variant Present in the following documents:
  • 13238_2014_Article_31.pdf
View BVdb publication page